[Carcinoid syndrome. II. Clinical manifestations, diagnosis, prognosis and treatment].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003967:Diarrhea / Q000209:etiology; D004837:Epinephrine; D006349:Heart Valve Diseases / Q000209:etiology; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008303:Malignant Carcinoid Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D009638:Norepinephrine; D011379:Prognosis; D012140:Respiratory Tract Diseases / Q000209:etiology
D000970:Antineoplastic Agents; D006897:Hydroxyindoleacetic Acid; D009638:Norepinephrine; D004837:Epinephrine
Sindrome carcinoide. II. Clínica, diagnóstico, pronóstico y tratamiento